On Tuesday, U.S. health authorities urged states and healthcare providers pause use of Johnson & Johnson’s coronavirus vaccine, citing reports of a rare but serious side effect. According to the Food and Drug Administration and the Centers for Disease Control and Prevention, six women in the U.S. have experienced an unusual combination of blood clots… Read More: The US paused use of J&J’s vaccine. What happens next? »
The J&J vaccine is the third authorised in the United States, following ones from Pfizer/BioNTech and Moderna, both of which require two doses. The US Food and Drug Administration announced the emergency use authorisation of the J&J vaccine for adults aged 18 and older following Friday’s unanimous endorsement by the agency’s panel of outside experts.… Read More: US authorises J&J’s COVID-19 vaccine, making it third available »
For years, Johnson & Johnson has vowed to appeal each talc verdict it lost, and the company cited a “fundamentally unfair process” and “multiple errors” when jurors in St. Louis ordered the company to pay $ 4.69 billion to 22 women with ovarian cancer. Now, an appeals court has reduced that award—but only to $ 2.11 billion, thanks to J&J’s “outrageous” and “reprehensible” defense of the product.… Read More: Judges slam J&J’s ‘reprehensible’ talc defense, cut massive 2018 verdict… »